B O O K - American College of Rheumatology

More documents

Recommendations

Info

ACR/ARHP Poster Session B 212 1037. Heptavalent Conjugate Pneumococcal Vaccine (Prevenarâ) Elicits Similar Antibody Responses as 23-Valent Polysaccharide Vaccine (PPV) in Adult Patients with Established Arthritis. Meliha C. Kapetanovic 1 , Carmen Roseman 2 , Göran Jönsson 1 , Lennart Truedsson 3 , Tore Saxne 1 and Pierre Geborek 1 , 1 Dept of Clinical Sciences Lund, Section of Infectious Diseases, Lund University, Lund, Sweden, 2 Dept of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, 3 Dept of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden. 1038. Higher Prevalence of Coexisting Papillary Thyroid Cancer as Well as Autoimmune Thyroid Diseases in Patients with Rheumatoid Arthritis. Yeon-Ah Lee 3 , Sang-Hoon Lee 1 , Ran Song 2 , Kyoung Min Son, Hyung-In Yang and Seung-Jae Hong 4 , 1 Seoul, Korea, Republic of, 2 Korea, Republic of, 3 Division of Rheumatology, Department of Internal Medicine, School of Medicine, KyungHee University, Seoul, Korea, Republic of, 4 Division of Rheumatology, Department of Internal Medicine, School of Medicine, KyungHee University. 1039. Hospital-Based Surgical Procedures and the Risk of Perioperative Cardiovascular Events: A Comparison Study of Rheumatoid Arthritis and Diabetes Mellitus Using the National Inpatient Sample of the Healthcare Cost and Utilization Project. Ali Yazdanyar 2 , Mary C. Wasko 3 , Kevin L. Kraemer 3 and Michael M. Ward 1 , 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2 St Luke’s Hospital, Bethlehem, PA, 3 University of Pittsburgh. 1040. Hypogonadism in Males with Rheumatoid Arthritis. Dannette S. Johnson and Robert W. McMurray, G.V. (Sonny) Montgomery VA and University of Mississippi Medical Center, Jackson, MS. 1041. Il-17 as a Novel Predictor of Vascular Damage in Rheumatoid Arthritis. Wendy Marder 2 , Shokoufeh Khalatbari 3 , James D. Myles 3 , Rita P. Hench 2 , Susan Lustig 1 , Robert D. Brook 1 and Mariana J. Kaplan 2 , 1 Division of Cardiology, University of Michigan, 2 Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3 Michigan Institute for Clinical and Health Research, Ann Arbor, MI. 1042. Incidence of Progressive Interstitial Pneumonia in Patients with Rheumatoid Arthritis. Yuko Takahashi, Hiroyuki Yamashita, Yo Ueda, Yuji Yoshida, Hiroshi Kaneko and Akio Mimori, Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjyuku-ku, Tokyo, Japan. 1043. Infertility in Women with RA and Pregnancy Loss in Women with SLE Contribute to Smaller Than Desired Family Size. Megan E. B. Clowse 3 , Eliza F. Chakravarty 1 , Karen H. Costenbader 2 , Christine D. Chambers 5 and Kaleb D. Michaud 4 , 1 Mountain View, CA, 2 Brigham & Women, Boston, MA, 3 Duke Univ Med, Durham, NC, 4 Univ of Nebraska Med Ctr, Omaha, NE, 5 University of California, San Diego. 1044. Interstitial Lung Disease in Rheumatoid Arthritis: Effect on Physical Function, Disability, Mental Health and Survival over a 10-Year Period. Inmaculada Del Rincon 2 , Jose Felix Restrepo 3 , Mrisa Sahai 2 , Daniel F. Battafarano 1 , L. Ricardo Zuniga-Montes 2 and Agustin Escalante 2 , 1 Brooke Army Medical Ctr, San Antonio, TX, 2 UTHSCSA, San Antonio, TX, 3 UTHSCSA, Bogota, Colombia. 1045. Lower Extremity Ulcers in Rheumatoid Arthritis. David M. DeMaria 2 , Christopher E. Attinger 1 and Victoria K. Shanmugam 2 , 1 Center for Wound Healing, Georgetown University Medical Center, Washington, DC, 2 Division of Rheumatology, Immunology and Allergy, Georgetown University Medical Center, Washington, DC. 2010 Program Book 1046. Lower Prevalence and Severity of “Vulnerable” Coronary Plaque in a-TNF-Exposed Asymptomatic Patients with Rheumatoid Arthritis (RA). George A. Karpouzas 1 , Naser Ahmadi 2 , Tae-Young Choi 2 , Fereshteh Hajsadeghi 2 , Silvia Munoz 2 and Mathew Budoff 2 , 1 Harbor-UCLA, Long Beach, CA, 2 Harbor- UCLA. 1047. Measuring Therapeutic Adherence in Rheumatoid Arthritis (RA) Using a Medication Event Monitoring System (MEMS®). Christian A. Waimann, Maria F. Marengo, Sofia de Achaval, Vanessa L. Cox, Araceli Garcia Gonzalez, Marsha N. Richardson and Maria E. Suarez-Almazor, The University of Texas MD Anderson Cancer Center, Houston, TX. 1048. Polyautoimmunity and Autoimmune Aggregation in Rheumatoid Arthritis. Adriana Rojas-Villarraga 1 , Ricardo A. Cifuentes 3 , Diana Botello-Corzo 3 , Antonio Iglesias-Gamarra 4 , Ruben D. Mantilla 5 and Juan-Manuel Anaya 2 , 1 Center for Autoimmune Diseases Research (CREA), Universidad del Rosario, 2 CREA, Universidad del Rosario, Bogota, Colombia, 3 CREA, Universidad del Rosario, 4 Rheumatology Unit, Universidad Nacional, 5 Riesgo de Fractura-CAYRE IPS. 1049. Prediction of 10-Year Cardiovascular and All-Cause Mortality in Rheumatoid Arthritis Using the Ankle-Brachial Index. Carlos Ramirez 3 , Agustin Escalante 2 , Mrisa Sahai 3 , Daniel F. Battafarano 1 , Samvel Pogosian 3 and Inmaculada Del Rincon 2 , 1 Brooke Army Medical Ctr, San Antonio, TX, 2 UTHSCSA, San Antonio, TX, 3 UTHSCSA. 1050. Prevalence and Predictors of Pain in Rheumatoid Arthritis Patients in DAS28 Remission. Yvonne C. Lee 1 , Jing Cui 3 , Bing Lu 2 , Michelle Frits 3 , Christine K. Iannaccone 3 , Nancy A. Shadick 4 , Michael E. Weinblatt 4 and Daniel Hal Solomon 4 , 1 Brigham & Womens Hospital, Boston, MA, 2 Brigham and Women’s Hospital, Foxboro, MA, 3 Brigham and Women’s Hospital, Boston, MA, 4 Brigham and Womens Hospital, Boston, MA. 1051. Rheumatoid Arthritis Patients in Clinical Remission Manifest Persistent Joint Inflammation on Histology and Imaging. Allen P. Anandarajah 1 , Ralf G. Thiele 2 , Johnny Monu 4 , Gwy-Suk Seo 3 , Aqiba Bokhari 3 and Christopher T. Ritchlin 5 , 1 Univ of Rochester Med Ctr, Rochester, NY, 2 University of Rochester, Rochester, NY, 3 University of Rochester, 4 University of Rochester Med Ctr, 5 University of Rochester Medical Center, Rochester, NY. 1052. Rheumatoid Arthritis Patients Receive Less Frequent Acute Reperfusion and Secondary Prevention after Myocardial Infarction. Sharon Van Doornum 4 , Caroline Brand 3 , Vijaya Sundararajan 1 , Andrew Ajani 3 and Ian Wicks 2 , 1 Monash University, 2 Royal Melbourne Hospital, Melbourne, Australia, 3 Royal Melbourne Hospital, 4 University of Melbourne, Victoria, Australia. 1053. Risk Factors for Coronary Heart Diseases in Japanese Patients with Rheumatoid Arthritis: From a Large Observational Study, IORRA. Eiichi Tanaka 1 , Eisuke Inoue 3 , Toru Yamada 3 , Ayako Nakajima 3 , Atsuo Taniguchi 3 , Shigeki Momohara 3 and Hisashi Yamanaka 2 , 1 Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 2 Institute of Rheumatology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan, 3 Institute of Rheumatology, Tokyo Women’s Medical University. 1054. Risk of Acute Coronary Syndromes in Relation to TNF- Inhibition in Early Rheumatoid Arthritis. Lotta Ljung 5 , Julia F. Simard 3 , Lennart T. H. Jacobsson 4 , Solbritt M. Rantapaa- Dahlqvist 1 and Johan Askling 2 , 1 Umea, Sweden, 2 Clinical Epidemiology Unit, 3 Clinical Epidemiology Unit, Stockholm, Sweden, 4 Malmo University Hospital, Malmo, Sweden, 5 Umea University Hospital.
ACR/ARHP Poster Session B 1055. Sonographic Guidance and the Injection of the Rheumatoid Joint. Courtney R. Johnson 4 , Natalia Chavez Chiang 1 , Suzanne Delea 1 , Hilliary Norton, Wilmer L. Sibbitt 2 and Arthur D. Bankhurst 3 , 1 Albuquerque, NM, 2 University of New Mexico HSC, Albuquerque, NM, 3 University of NM Med Ctr, Albuquerque, NM, 4 UNM Carrie Tingley Hospital, Albuquerque, NM. 1056. Statin Discontinuation and Risk of Acute Myocardial Infarction in Rheumatoid Arthritis: A Population-Based Study. Mary A. De Vera 1 , Hyon K. Choi 5 , Michal Abrahamowicz 3 , Jacek Kopec 1 , Maria Victoria Goycochea-Robles 4 and Diane V. Lacaille 2 , 1 Arthritis Research Centre of Canada, Vancouver, BC, Canada, 2 Arthritis Research Ctr Canada, Vancouver, BC, Canada, 3 McGill University, Montreal, QC, Canada, 4 Research Unit of Clinical Epidemiology, Hospital Regional 1 IMSS, Mexico City, Mexico, 5 Univ of British Columbia, Vancouver, BC, Canada. 1057. Stroke in Rheumatoid Arthritis: (When) Is There an Increased Risk? Marie E. Holmqvist 1 , Lennart T. H. Jacobsson 3 , Lars Alfredsson 1 and Johan Askling 2 , 1 Karolinska Institutet, 2 Karolinska University Hospital, 3 Malmö University Hospital. 1058. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis Is Associated with Decreased Activity of Lecithin Cholesterol Acyl: Transferase, a High Density Lipoprotein (HDL)-Associated Protein Involved in Reverse Cholesterol Transport. Christina Charles-Schoeman 2 , Yuen Yin Lee 3 , Sogol Amjadi 3 , John D. FitzGerald 4 , Veena K. Ranganath 2 , Mihaela Taylor 3 , Maureen A. McMahon 2 , Harold E. Paulus 1 and Srinivasa T. Reddy 3 , 1 Encino, CA, 2 UCLA School of Medicine, Los Angeles, CA, 3 UCLA School of Medicine, 4 UCLA School of Medicine Rehabilitation, Los Angeles, CA. 1059. Symptomatic Heart Failure, NT-proBNP Levels, and Diastolic Dysfunction in RA-Patients with and without Anti-TNFa Therapy. A Prospective Consecutive Cohort Study. Michael Gottwald 1 , Denio Ridjab 2 , Stephanie Glocke 1 , Kathrin Behring 1 , Robert Lange 3 , Christian Butter 1 and Michael Zaenker 1 , 1 EFKH and Heart Center Brandenburg, Bernau, Germany, 2 EFKH and Heart Center Brandenburg, Bernau, Germany, 3 Hospitalverbund and Rheumazentrum Nord-Brandenburg. 1060. The Clinical Features of 13 Women with Microchimerism in Rheumatoid Nodules. Christopher J. Atkins 4 , William F. N. Chan 1 , David Naismith 6 , Nicholas van der Westhuizen 6 , Janet Woo 3 , Valerie Cortez 5 and J. Lee Nelson 2 , 1 Fred Hutchinson Cancer Research Center, 2 Fred Hutchinson Cancer Research Center and University of Washington, 3 University of British Columbia, 4 University of Victoria, Victoria, BC, Canada, 5 University of Washington, 6 Vancouver Island Health Authority. 1061. The Clinical Implication of Anti-Cyclic Citrullinated Peptide Antibody in Late Onset Rheumatoid Arthritis. Se Jin Jung 3 , Yoon Kang 3 , You-Jung Ha 3 , Kwang-Hoon Lee 3 , Sang Won Lee 3 , Min-Chan Park 1 , Soo Kon Lee 2 and Yong-Beom Park, 1 Gangnam Severance Hospital, Seoul, Korea, Republic of, 2 Yonsei Univ College of Med, Seoul, Korea, Republic of, 3 Yonsei Univ College of Med. 1062. The Effect of Calcium and Vitamin D Supplementation on the Incidence of Rheumatoid Arthritis in the Women’s Health Initiative Randomized Study. Marius Racovan 10 , Brian Walitt 10 , Christopher Collins 10 , Mary Pettinger 2 , Christine Parks 4 , James Shikany 6 , Jean Wactawski-Wende 8 , JoAnn E. Manson 1 , Larry Moreland 9 , Nicole Wright 7 , Rebecca Jackson 5 and Barbara V. Howard 3 , 1 Brigham and Women’s Hospital, Harvard Medical School, 2 Fred Hutchinson Cancer Research Center, 3 MedStar Research Institute, 4 National Institute of Enviromental Health Sciences, 5 Ohio State University, 6 University of Alabama, 7 University of Arizona, 8 University of Buffalo, 9 University of Pittsburgh, 10 Washington Hospital Center. 1063. The Impact of Rheumatoid Arthritis (RA) on Women: Focus on Pain, Productivity and Relationships. Vibeke Strand 2 , Paul Emery 1 , Scott Fleming 4 and Catherine Griffin 3 , 1 Chapel Allerton Hospital, Leeds, United Kingdom, 2 Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, 3 Echo Research, London, UK, 4 UCB, Slough, UK. 1064. There Are No Differences in Lipids between RA Patients and Their Siblings, Despite Higher Incidence of CHD in RA. Namita Kumar, Nicola J. Marshall, David J. Walker and Philip N. Platt, University Hospital of North Durham. 1065. Thigh Fat and Muscle in Rheumatoid Arthritis: Associations with Disease Features and Physical Functioning. Henry R. Kramer 1 , Kevin R. Fontaine 1 , Joan M. Bathon 1 and Jon T. Giles 2 , 1 Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 2 Johns Hopkins Univ, Baltimore, MD. 1066. TNF Inhibitors and the Risk of Fracture in Rheumatoid Arthritis. Daniel Hal Solomon 3 , Seo Young Kim 1 , Jun Liu 2 , Claire Canning 2 and Sebastian Schneeweiss 2 , 1 Brigham and Women’s Hospital, Boston, MA, 2 Brigham and Women’s Hospital, 3 Brigham and Womens Hospital, Boston, MA. 1067. Traditional and Novel Risk Markers for Atherosclerosis but Not Clinical Measures of Inflammatory Disease Are Associated with Atheromatous Plaque Presence in Early Inflammatory Polyarthritis-Results from the Norfolk Arthritis Register (NOAR). Hoda Mirjafari 3 , Suzanne M. M. Verstappen 2 , Diane Bunn 6 , Helena Edlin 5 , Valentine Charlton-Menys 4 , Philip Pemberton 5 , Tarnya Marshall 6 , Paddy Wilson 6 , Mark Lunt 2 , Deborah P. Symmons 7 and Ian N. Bruce 1 , 1 Arthritis Research UK Epidemiology Unit, Stopford Building, The University of Manchester, Manchester, United Kingdom, 2 Arthritis Research UK Epidemiology Unit, Stopford Building, The University of Manchester, 3 Arthritis Research UK Epidemiology Unit, The University of Manchester, 4 Cardiovascular Research Group, The University of Manchester, 5 Manchester Royal Infirmary, 6 Norfolk and Norwich University Hospital, 7 Univ of Manchester, Manchester, United Kingdom. 1068. Unaffected First-Degree Relatives of RA Patients Exhibit a High Prevalence of Joint Symptoms That Is Not Explained by the Presence of RA Autoantibodies: Studies in a Predisposed North American Native Population. Irene Smolik 3 , Qier Tan 3 , Xikui Wang 3 , Donna Hart 3 , Marianna Newkirk 1 , Charles N. Bernstein 3 , David B. Robinson 3 and Hani S. El-Gabalawy 2 , 1 McGill University, 2 University of Manitoba, Winnipeg, MB, Canada, 3 University of Manitoba. Rheumatoid Arthritis - Human Etiology and Pathogenesis II 1069. ‘Shared’ T-Cell Clones Identified in Lymph Nodes and Synovial Tissue of Early Rheumatoid Arthritis Patients Using a Novel High Throughput Sequencing Technology. Paul L. Klarenbeek 4 , Marjolein J. de Hair 4 , Stefano Alivernini 4 , Marleen G. van de Sande 4 , Marieke E. Doorenspleet 4 , Barbera D. van Schaik 3 , Ferco H. Berger 2 , Rebecca E. Esveldt 4 , Antoine H. van Kampen 3 , Danielle M. Gerlag 4 , Frank Baas 5 , Paul P. Tak 1 and Niek de Vries 4 , 1 Academic Med Ctr/Univ of Amsterdam, Amsterdam, The Netherlands, 2 Dept of Radiology, Academic Medical Center-University of Amsterdam, 3 Dept. of Clin. Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center- University of Amsterdam, 4 Div of Clin Immunology & Rheumatology, Academic Medical Center-University of Amsterdam, Amsterdam, The Netherlands, 5 Lab. For Genome Analysis, Academic Medical Center-University of Amsterdam. 2010 Program Book 213
Page 1 and 2:
program B O O K Pre-Conference Cour
Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
Page 11 and 12:
the written consent of the ACR is p
Page 13 and 14:
Shuttle Bus Service See shuttle sig
Page 15 and 16:
ACR Resource Center Hours: Sunday,
Page 17 and 18:
ACR Hotels + Map Complimentary shut
Page 19 and 20:
to the premier meeting in rheumatol
Page 21 and 22:
ACR Clinical Research Conference c/
Page 23 and 24:
4:20 PM Germinal Center Reactions A
Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
Page 27 and 28:
Upon completion of this session, pa
Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
Page 31 and 32:
B301 Dermatological Manifestations
Page 33 and 34:
Session Overview: The innate immune
Page 35 and 36:
Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
Page 39 and 40:
and insufficiency • recall source
Page 41 and 42:
Session Overview: The advent of bio
Page 43 and 44:
2:45 pm 641. Major Improvements in
Page 45 and 46:
5 University of Twente and Medisch
Page 47 and 48:
ACR/ARHP Combined Abstract Session
Page 49 and 50:
REF 25th Anniversary Celebration 2:
Page 51 and 52:
5:45 PM 699. Defining Latent and/or
Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
Page 59 and 60:
• discuss the principles of early
Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
Page 65 and 66:
ACR Plenary Session II: Discovery 2
Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
Page 69 and 70:
Session Overview: As a clinical edu
Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
Page 77 and 78:
2:45 PM 1405. Development of a Visi
Page 79 and 80:
4:30 PM Anti-citrullinated Protein
Page 81 and 82:
of Experimental Orthopedics, Univer
Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
Page 91 and 92:
• compare the prevalence and epid
Page 93 and 94:
6:45 PM Macrophage Activation Syndr
Page 95 and 96:
Page 97 and 98:
Session Overview: This roundtable d
Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
Page 103 and 104:
• describe the role of IL-1 and I
Page 105 and 106:
Session Overview: For the clinician
Page 107 and 108:
• identify the aspects for day-to
Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
Page 111 and 112:
Session Overview: Ultrasound and ma
Page 113 and 114:
Session Overview: Fifty percent of
Page 115 and 116:
1:20 PM Academic Rheumatology Seth
Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
Page 123 and 124:
Session Overview: We are witnessing
Page 125 and 126:
Session Overview: Systemic sclerosi
Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
Page 131 and 132:
4:30 PM 2198. Association between V
Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
Page 137 and 138:
• apply these basic statistics to
Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
Page 141 and 142:
Immunology, Oslo University Hospita
Page 143 and 144:
9:15 AM 2239. Factors Associated wi
Page 145 and 146:
Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
Page 151 and 152:
ACR Poster Session A Cytokines, Med
Page 153 and 154:
ACR Poster Session A 51. Associatio
Page 155 and 156:
ACR Poster Session A 83. Respirator
Page 157 and 158:
ACR Poster Session A 121. Bone Dens
Page 159 and 160:
ACR Poster Session A 142. The Intra
Page 161 and 162:
ACR Poster Session A 171. Early Pro
Page 163 and 164: ACR Poster Session A Pediatric Rheu
Page 165 and 166: ACR Poster Session A 233. Prevalenc
Page 167 and 168: ACR Poster Session A 266. Subtype S
Page 169 and 170: ACR Poster Session A 297. Body Weig
Page 171 and 172: ACR Poster Session A 325. Patient R
Page 173 and 174: ACR Poster Session A 356. Influence
Page 175 and 176: ACR Poster Session A 383. Efficacy
Page 177 and 178: ACR Poster Session A 409. Rituximab
Page 179 and 180: ACR Poster Session A 441. Recombina
Page 181 and 182: ACR Poster Session A 465. Immunoglo
Page 183 and 184: ACR Poster Session A 496. IRF8 Alle
Page 185 and 186: ACR Poster Session A 521. DC-STAMP
Page 187 and 188: ACR Poster Session A 546. Prevalenc
Page 189 and 190: ACR Poster Session A 571. Epidemiol
Page 191 and 192: ACR Poster Session A 599. Validatio
Page 193 and 194: ACR/ARHP Poster Session B Halls B1
Page 195 and 196: ACR Poster Session B 767. Economic
Page 197 and 198: ACR/ARHP Poster Session B 792. The
Page 199 and 200: ACR/ARHP Poster Session B Universit
Page 201 and 202: ACR/ARHP Poster Session B 848. Cell
Page 203 and 204: ACR/ARHP Poster Session B 886. Scre
Page 205 and 206: ACR/ARHP Poster Session B 909. Regu
Page 207 and 208: ACR/ARHP Poster Session B 935. The
Page 209 and 210: ACR/ARHP Poster Session B 967. Frac
Page 211 and 212: ACR Poster Session B 993. Early Exp
Page 213: ACR/ARHP Poster Session B 1022. Com
Page 217 and 218: ACR Poster Session B 1084. Gene Exp
Page 219 and 220: ACR/ARHP Poster Session B 1111. Inc
Page 221 and 222: ACR Poster Session B hiroshima Memo
Page 223 and 224: ACR/ARHP Poster Session B 1166. Pre
Page 225 and 226: ACR/ARHP Poster Session B 1199. Typ
Page 227 and 228: ACR/ARHP Poster Session B 1225. Phy
Page 229 and 230: ACR/ARHP Poster Session B 1262. Lat
Page 231 and 232: ACR/ARHP Poster Session B 1294. End
Page 233 and 234: ACR/ARHP Poster Session B 1321. Cha
Page 235 and 236: ACR/ARHP Poster Session C Halls B1
Page 237 and 238: ACR/ARHP Poster Session C 1495. S10
Page 239 and 240: ACR/ARHP Poster Session C 1524. Inc
Page 241 and 242: ACR/ARHP Poster Session C 1555. Pro
Page 243 and 244: ACR/ARHP Poster Session C 1583. Ass
Page 245 and 246: ACR/ARHP Poster Session C 1596. Gen
Page 247 and 248: ACR/ARHP Poster Session C 1622. Flu
Page 249 and 250: ACR/ARHP Poster Session C Miscellan
Page 251 and 252: ACR/ARHP Poster Session C L. Woodwa
Page 253 and 254: ACR/ARHP Poster Session C 1692. Res
Page 255 and 256: ACR/ARHP Poster Session C 1719. Los
Page 257 and 258: ACR/ARHP Poster Session C 1749. Con
Page 259 and 260: ACR/ARHP Poster Session C 1780. Tow
Page 261 and 262: ACR/ARHP Poster Session C 1804. Eff
Page 263 and 264: ACR/ARHP Poster Session C Immunolog
Page 265 and 266:
ACR/ARHP Poster Session C 2 Departm
Page 267 and 268:
ACR/ARHP Poster Session C CA, 29 Un
Page 269 and 270:
ACR/ARHP Poster Session C 1900. IL-
Page 271 and 272:
ACR/ARHP Poster Session C 1930. Cor
Page 273 and 274:
ACR/ARHP Poster Session C 1958. The
Page 275 and 276:
ACR/ARHP Poster Session C 1988. Cha
Page 277 and 278:
ACR/ARHP Poster Session C 2015. CpG
Page 279 and 280:
ACR/ARHP Poster Session C 2038. Pri
Page 281 and 282:
ACR/ARHP Poster Session C 2070. Ass
Page 283 and 284:
REF Industry Roundtable-supported S
Page 285 and 286:
REF Industry Roundtable-supported S
Page 287 and 288:
INDUSTRY-SUPPORTED POST-CONFERENCE
Page 289 and 290:
2010 ACR/ARHP Annual Meeting Leader
Page 291 and 292:
2010 ACR/ARHP Annual Meeting Leader
Page 293 and 294:
FLOOR PLANS 2010 Program Book 291
Page 295 and 296:
VISIT THE EXHIBIT HALL New and inno
Page 297 and 298:
EXHIBITORS La Lettre Du Rhumatologu
Page 299 and 300:
ACKNOWLEDGEMENTS The ACR, the ARHP
Page 301 and 302:
ACR/ARHP/REF STAFF LISTING Administ
Page 303 and 304:
A Ahmed, Rafi, PhD T cell Memory .
Page 305 and 306:
Cooper, Max D, MD Introduction . .
Page 307 and 308:
Gerlag, Danielle Marie, MD, PhD The
Page 309 and 310:
Physical Examination Skills for Imp
Page 311 and 312:
Meroni, Pierluigi, MD Autoantibodie
Page 313 and 314:
Rogers, Joan C, PhD, OTR/ L Underst
Page 315 and 316:
Terkeltaub, Robert, MD Crystallizin
Page 317 and 318:
A Aarden, L 1825 Aarrass, S 1519, 1
Page 319 and 320:
Bakker, AAB 1095 Barendregt, B 753
Page 321 and 322:
Boutin-Le Thi Huong, D 478 Bout-Tab
Page 323 and 324:
Chatham, WW 457, 1146, 1454, 1457,
Page 325 and 326:
Daudon, M 875 Daugas, E 2009 Davatc
Page 327 and 328:
Ehst, B 758 Eicher, JL 688 Eisen, S
Page 329 and 330:
Gabay, OH 1484 Gaber, T 630, 1418 G
Page 331 and 332:
Guan, M 965 Guañabens, N 975 Gudbj
Page 333 and 334:
Homme, CL 730 Honda, E 434 Hong, JY
Page 335 and 336:
Kambayashi, T 1354 Kamdar, AA 1160
Page 337 and 338:
Kuller, LH 71 Kumabe, M 1164 Kumaga
Page 339 and 340:
Looney, C 941 Looney, MR 609 Looney
Page 341 and 342:
McCarthy, GM 1109, 1306, 1426 McCau
Page 343 and 344:
Myouzen, K 1577 Mysiw, WJ 2096 Mysl
Page 345 and 346:
Pans, M 1834 Parra, ER 605, 887 Ped
Page 347 and 348:
Radka, S 1174 Radner, H 296, 1745 R
Page 349 and 350:
Sack, KE 1898 Sacli, SF 1312 Saddic
Page 351 and 352:
1463, 2071, 2140, 2141 Singh, K 212
Page 353 and 354:
Takahata, M 1492 Takasaki, Y 1731 T
Page 355 and 356:
636 van Dongen, CJJ 90 Van Doornum,
Page 357 and 358:
Witte, T 824, 1578, 1579, 2214 Witt
Page 359 and 360:
A α-galactosylceramide 505 A2A kno
Page 361 and 362:
Behcet’s syndrome 1284, 1288, 129
Page 363 and 364:
cost-utility 759, 1539 couples 1324
Page 365 and 366:
fibroblast like synoviocyte 27 fibr
Page 367 and 368:
impact 1063, 1325 inactive disease
Page 369 and 370:
methylation 826, 1253, 1489 methylt
Page 371 and 372:
233, 234, 240, 243, 252, 262, 268,
Page 373 and 374:
1599, 1600, 1603, 1605, 1606, 1609,
Page 375 and 376:
1226, 1227, 1229, 1230, 1231, 1233,
Page 377 and 378:
Abelson, Abby Goulder, MD Education
Page 379 and 380:
Massarotti, Elena M, MD Systemic Lu
Page 381 and 382:
ACR Annual Meeting fellowS-in-train
Page 383 and 384:
NOTES 2010 Program Book 381
Page 385 and 386:
Enbrel ® (etanercept) Brief Summar
Page 387 and 388:
Prescription Enbrel ® (etanercept)
show all

B O O K - American College of Rheumatology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?